The presence of multiple NS5A RASs is associated with the outcome of sofosbuvir and ledipasvir therapy in NS5A inhibitor-naïve patients with chronic HCV genotype 1b infection in a real-world cohort.
about
The presence of multiple NS5A RASs is associated with the outcome of sofosbuvir and ledipasvir therapy in NS5A inhibitor-naïve patients with chronic HCV genotype 1b infection in a real-world cohort.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The presence of multiple NS5A ...... ection in a real-world cohort.
@en
The presence of multiple NS5A ...... ection in a real-world cohort.
@nl
type
label
The presence of multiple NS5A ...... ection in a real-world cohort.
@en
The presence of multiple NS5A ...... ection in a real-world cohort.
@nl
prefLabel
The presence of multiple NS5A ...... ection in a real-world cohort.
@en
The presence of multiple NS5A ...... ection in a real-world cohort.
@nl
P2093
P2860
P356
P1476
The presence of multiple NS5A ...... ection in a real-world cohort.
@en
P2093
A Hagihara
H Morikawa
H Motoyama
S Uchida-Kobayashi
Y Murakami
P2860
P304
P356
10.1111/JVH.12850
P577
2017-12-23T00:00:00Z